ClinVar Miner

Submissions for variant NM_000489.6(ATRX):c.6235C>T (p.Arg2079Ter)

dbSNP: rs2148020083
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003624466 SCV004430364 pathogenic Alpha thalassemia-X-linked intellectual disability syndrome 2023-02-13 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg2079*) in the ATRX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATRX are known to be pathogenic (PMID: 15591283, 18409179, 23681356). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATRX-related conditions. ClinVar contains an entry for this variant (Variation ID: 1334885). For these reasons, this variant has been classified as Pathogenic.
Genome Sciences Centre, British Columbia Cancer Agency RCV001815150 SCV002062053 uncertain significance Adrenal cortex carcinoma 2022-01-20 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.